Concurrently, S&P affirmed the “AA+” long-term rating and underlying rating on Inova’s outstanding debt.
The assignment and affirmations are a result of Inova’s strong enterprise profile, characterized by its leading market share, wide array of service offerings and favorable service area. In addition, S&P acknowledged Inova’s strong financial performance, low leverage and high unrestricted reserves.
The outlook is stable, reflecting S&P’s expectation that Inova will maintain its healthy operating results to meet long-term capital needs.
More articles on healthcare finance:
Hospitals are moving to single ratings: Here’s why
Fitch: Minor headwinds coming for US children’s hospitals
Walgreens, CVS, Rite-Aid shares plummet after Amazon buys Pillpack
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
